• Latest Posts

67% five-year survival rate in glioblastoma therapy, according to CANbridge Pharmaceuticals study

Likang gets trial ok for China’s first personalized cancer vaccine 

Purple Biotech sees positive results from cancer study

How cancer cells repair DNA damage from radiotherapy

ADVERTISEMENT

Greener Pastures for Biotech? 7 Great Biotechs from Ireland

Inspire Biotherapeutics launches to target lung diseases through gene therapy

Mediar Therapeutics boosts fibrosis portfolio with $105M financing

Nanite receives funding to deliver genetic therapies to the lungs

Cambrian Bio to boost aging pipeline with Amplifier Therapeutics launch

10 immunotherapy companies making waves in 2023

ADVERTISEMENT